103 related articles for article (PubMed ID: 9464485)
21. Tamoxifen: is it safe? Comparison of activation and detoxication mechanisms in rodents and in humans.
White IN
Curr Drug Metab; 2003 Jun; 4(3):223-39. PubMed ID: 12769667
[TBL] [Abstract][Full Text] [Related]
22. Formation of 8-hydroxydeoxyguanosine in calf thymus DNA treated in vitro with phenylhydroquinone, the major metabolite of O-phenylphenol.
Nagai F; Ushiyama K; Satoh K; Kasai H; Kano I
Carcinogenesis; 1995 Apr; 16(4):837-40. PubMed ID: 7728964
[TBL] [Abstract][Full Text] [Related]
23. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
24. Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.
Umemoto A; Monden Y; Lin CX; Abdul-Momen M; Ueyama Y; Komaki K; Laxmi YR; Shibutani S
Chem Res Toxicol; 2004 Dec; 17(12):1577-83. PubMed ID: 15606132
[TBL] [Abstract][Full Text] [Related]
25. 4-Hydroxytamoxifen gives DNA adducts by chemical activation, but not in rat liver cells.
Osborne MR; Davis W; Hewer AJ; Hardcastle IR; Phillips DH
Chem Res Toxicol; 1999 Feb; 12(2):151-8. PubMed ID: 10027792
[TBL] [Abstract][Full Text] [Related]
26. Mutagenicity of tamoxifen DNA adducts in human endometrial cells and in silico prediction of p53 mutation hotspots.
Liapis E; McLuckie KI; Lewis PD; Farmer PB; Brown K
Nucleic Acids Res; 2008 Oct; 36(18):5933-45. PubMed ID: 18805907
[TBL] [Abstract][Full Text] [Related]
27. Implications of tamoxifen metabolism in the athymic mouse for the study of antitumor effects upon human breast cancer xenografts.
Robinson SP; Langan-Fahey SM; Jordan VC
Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1769-76. PubMed ID: 2632258
[TBL] [Abstract][Full Text] [Related]
28. Biotransformation of tamoxifen in a human endometrial explant culture model.
Sharma M; Shubert DE; Sharma M; Lewis J; McGarrigle BP; Bofinger DP; Olson JR
Chem Biol Interact; 2003 Dec; 146(3):237-49. PubMed ID: 14642736
[TBL] [Abstract][Full Text] [Related]
29. Activation of tamoxifen and its metabolite alpha-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes.
Phillips DH; Carmichael PL; Hewer A; Cole KJ; Hardcastle IR; Poon GK; Keogh A; Strain AJ
Carcinogenesis; 1996 Jan; 17(1):89-94. PubMed ID: 8565142
[TBL] [Abstract][Full Text] [Related]
30. Interactions of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen with P-glycoprotein and CYP3A.
Bekaii-Saab TS; Perloff MD; Weemhoff JL; Greenblatt DJ; von Moltke LL
Biopharm Drug Dispos; 2004 Oct; 25(7):283-9. PubMed ID: 15386482
[TBL] [Abstract][Full Text] [Related]
31. Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen.
Dasaradhi L; Shibutani S
Chem Res Toxicol; 1997 Feb; 10(2):189-96. PubMed ID: 9049430
[TBL] [Abstract][Full Text] [Related]
32. DNA binding of tamoxifen and its analogues: identification of the tamoxifen-DNA adducts in rat liver.
Rajaniemi H; Koskinen M; Mäntylä E; Hemminki K
Toxicol Lett; 1998 Dec; 102-103():453-7. PubMed ID: 10022295
[TBL] [Abstract][Full Text] [Related]
33. Prooxidant action of gallic acid compounds: copper-dependent strand breaks and the formation of 8-hydroxy-2'-deoxyguanosine in DNA.
Yoshino M; Haneda M; Naruse M; Htay HH; Iwata S; Tsubouchi R; Murakami K
Toxicol In Vitro; 2002 Dec; 16(6):705-9. PubMed ID: 12423653
[TBL] [Abstract][Full Text] [Related]
34. Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen.
Osborne MR; Hewer A; Hardcastle IR; Carmichael PL; Phillips DH
Cancer Res; 1996 Jan; 56(1):66-71. PubMed ID: 8548777
[TBL] [Abstract][Full Text] [Related]
35. Peroxidase activation of 4-hydroxytamoxifen to cause DNA damage in vitro.
Davies AM; Malone ME; White IN
Biochem Soc Trans; 1995 Aug; 23(3):439S. PubMed ID: 8566328
[No Abstract] [Full Text] [Related]
36. Benzo[a]pyrene enhances the formation of 8-hydroxy-2'-deoxyguanosine by ultraviolet A radiation in calf thymus DNA and human epidermoid carcinoma cells.
Liu Z; Lu Y; Rosenstein B; Lebwohl M; Wei H
Biochemistry; 1998 Jul; 37(28):10307-12. PubMed ID: 9665739
[TBL] [Abstract][Full Text] [Related]
37. Genotoxic, epigenetic, and transcriptomic effects of tamoxifen in mouse liver.
de Conti A; Tryndyak V; Churchwell MI; Melnyk S; Latendresse JR; Muskhelishvili L; Beland FA; Pogribny IP
Toxicology; 2014 Nov; 325():12-20. PubMed ID: 25123088
[TBL] [Abstract][Full Text] [Related]
38. Tamoxifen reduces endogenous and UV light-induced oxidative damage to DNA, lipid and protein in vitro and in vivo.
Wei H; Cai Q; Tian L; Lebwohl M
Carcinogenesis; 1998 Jun; 19(6):1013-8. PubMed ID: 9667739
[TBL] [Abstract][Full Text] [Related]
39. Induction of 8-hydroxydeoxyguanosine in DNA by chromium(III) plus hydrogen peroxide and its prevention by scavengers.
Tsou TC; Chen CL; Liu TY; Yang JL
Carcinogenesis; 1996 Jan; 17(1):103-8. PubMed ID: 8565117
[TBL] [Abstract][Full Text] [Related]
40. Short-term dosing of alpha-hydroxytamoxifen results in DNA damage but does not lead to liver tumours in female Wistar/Han rats.
White IN; Carthew P; Davies R; Styles J; Brown K; Brown JE; Smith LL; Martin EA
Carcinogenesis; 2001 Apr; 22(4):553-7. PubMed ID: 11285188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
